Sheaff Brock Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $705K | Buy |
1,454
+316
| +28% | +$153K | 0.06% | 216 |
|
|
2024
Q4 | $458K | Buy |
1,138
+29
| +3% | +$11.7K | 0.04% | 267 |
|
|
2024
Q3 | $516K | Sell |
1,109
-110
| -9% | -$51.2K | 0.05% | 247 |
|
|
2024
Q2 | $571K | Buy |
1,219
+26
| +2% | +$12.2K | 0.05% | 230 |
|
|
2024
Q1 | $499K | Buy |
1,193
+273
| +30% | +$114K | 0.03% | 284 |
|
|
2023
Q4 | $374K | Buy |
920
+17
| +2% | +$6.92K | 0.03% | 304 |
|
|
2023
Q3 | $314K | Buy |
903
+4
| +0.4% | +$1.39K | 0.03% | 317 |
|
|
2023
Q2 | $316K | Sell |
899
-52
| -5% | -$18.3K | 0.03% | 330 |
|
|
2023
Q1 | $300K | Sell |
951
-28
| -3% | -$8.82K | 0.03% | 339 |
|
|
2022
Q4 | $283K | Sell |
979
-69
| -7% | -$19.9K | 0.03% | 347 |
|
|
2022
Q3 | $303K | Buy |
1,048
+8
| +0.8% | +$2.31K | 0.03% | 323 |
|
|
2022
Q2 | $293K | Buy |
+1,040
| New | +$293K | 0.02% | 337 |
|